Skip to content
← Back to this collection

PUBLICATIONS · 37269841

Health-related quality of life and pain outcomes with [(177)Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2023 Jun
First author
Fizazi K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Fizazi K
      type
      Author
    2. name
      Herrmann K
      type
      Author
    3. name
      Krause BJ
      type
      Author
    4. name
      Rahbar K
      type
      Author
    5. name
      Chi KN
      type
      Author
    6. name
      Morris MJ
      type
      Author
    7. name
      Sartor O
      type
      Author
    8. name
      Tagawa ST
      type
      Author
    9. name
      Kendi AT
      type
      Author
    10. name
      Vogelzang N
      type
      Author
    11. name
      Calais J
      type
      Author
    12. name
      Nagarajah J
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Fizazi K
      type
      Author
    2. name
      Herrmann K
      type
      Author
    3. name
      Krause BJ
      type
      Author
    4. name
      Rahbar K
      type
      Author
    5. name
      Chi KN
      type
      Author
    6. name
      Morris MJ
      type
      Author
    7. name
      Sartor O
      type
      Author
    8. name
      Tagawa ST
      type
      Author
    9. name
      Kendi AT
      type
      Author
    10. name
      Vogelzang N
      type
      Author
    11. name
      Calais J
      type
      Author
    12. name
      Nagarajah J
      type
      Author
    bibliography ids
    1. nci-bib-affc2f421a55b7a3131d4ecc
    book metadata
    content sha256
    edc0705e8a9004d7e803dc5d0f438ed88ebb1a0e801ad0b1ab5d47efd266b9df
    document type
    citation
    dois
    1. 10.1016/S1470-2045(23)00158-4
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37269841
    immutable id
    pubmed:37269841@edc0705e8a9004d7e803dc5d0f438ed88ebb1a0e801ad0b1ab5d47efd266b9df
    journal
    abbreviation
    Lancet Oncol
    issn electronic
    1474-5488
    issn print
    1470-2045
    issue
    6
    name
    The Lancet. Oncology
    nlm unique id
    100957246
    pages
    597-610
    volume
    24
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37269841
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      99f5f9bbc18849914375c0c1fae515b8c529faf3590bf2173a940c3cd0669a85
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Jun
      precision
      month
      year
      2023
      publication types
      1. Randomized Controlled Trial
      2. Multicenter Study
      3. Clinical Trial, Phase III
      4. Journal Article
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37269841/
      title
      Health-related quality of life and pain outcomes with [(177)Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.

      Preserved source evidence · Not medical advice